|
1
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Virani S, Bilheem S, Chansaard W,
Chitapanarux I, Daoprasert K, Khuanchana S, Leklob A, Pongnikorn D,
Rozek LS, Siriarechakul S, et al: National and subnational
population-based incidence of cancer in thailand: Assessing cancers
with the Highest Burdens. Cancers (Basel). 9(pii): E1082017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bosch FX, Burchell AN, Schiffman M,
Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK and
Muñoz N: Epidemiology and natural history of human papillomavirus
infections and type-specific implications in cervical neoplasia.
Vaccine. 26 (Suppl 10):K1–K16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tulay P and Serakinci N: The role of human
papillomaviruses in cancer progression. J Cancer Metastasis Treat.
2:201–213. 2016. View Article : Google Scholar
|
|
5
|
Yeo-Teh NSL, Ito Y and Jha S: High-risk
human papillomaviral oncogenes E6 and E7 target key cellular
pathways to achieve oncogenesis. Int J Mol Sci. 19(pii): E17062018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sen P, Ganguly P and Ganguly N: Modulation
of DNA methylation by human papillomavirus E6 and E7 oncoproteins
in cervical cancer. Oncol Lett. 15:11–22. 2018.PubMed/NCBI
|
|
7
|
Yin F, Wang N, Wang S, Yu F, Sun X, Yu X,
Luo B, Zhao C and Wang Y: HPV16 oncogenes E6 or/and E7 may
influence the methylation status of RASSFIA gene promoter region in
cervical cancer cell line HT-3. Oncol Rep. 37:2324–2334. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yanatatsaneejit P, Mutirangura A and
Kitkumthorn N: Human papillomavirus's physical state and cyclin A1
promoter methylation in cervical cancer. Int J Gyneco. 21:902–906.
2011. View Article : Google Scholar
|
|
9
|
Chung CH and Gillson ML: Human
papillomavirus in head and neck cancer: Its role in pathogenesis
and clinical implications. Clin Cancer Res. 15:6758–6762. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sartor MA, Dolinoy DC, Jones TR, Colacino
JA, Prince ME, Carey TE and Rozek LS: Genome-wide methylation and
expression differences in HPV(+) and HPV(−) squamous cell carcinoma
cell lines are consistent with divergent mechanisms of
carcinogenesis. Epigenetics. 6:777–787. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lechner M, Fenton T, West J, Wilson G,
Feber A, Henderson S, Thirlwell C, Dibra HK, Jay A, Butcher L, et
al: Identification and functional validation of HPV-mediated
hypermethylation in head and neck squamous cell carcinoma. Genome
Med. 5:152013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kitkumthorn N, Yanatatsanajit P,
Kiatpongsan S, Phokaew C, Triratanachat S, Trivijitsilp P,
Termrungruanglert W, Tresukosol D, Niruthisard S and Mutirangura A:
Cyclin A1 promoter hypermethylation in human
papillomavirus-associated cervical cancer. BMC Cancer. 6:552006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chujan S, Kitkumthorn N, Siriangkul S and
Mutirangura A: CCNA1 promoter methylation: A potential marker for
grading Papanicolaou smear cervical squamous intraepithelial
lesions. Asian Pac J Cancer Prev. 15:7971–7975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chalertpet K, Pakdeechaidan W, Patel V,
Mutirangura A and Yanatatsaneejit P: Human papillomavirus type 16
E7 oncoprotein mediates CCNA1 promoter methylation. Cancer Sci.
106:1333–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Steenbergen RD, Kramer D, Braakhuis BJ,
Stern PL, Verheijen RH, Meijer CJ and Snijders PJ: TSLC1 gene
silencing in cervical cancer cell lines and cervical neoplasia. J
Natl Cancer Inst. 96:294–305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Banzai C, Nishino K, Quan J, Yoshihara K,
Sekine M, Yahata T and Tanaka K; Gynecological Cancer Registry of
Niigata, : Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A
genes in cervical carcinoma. Int J Clin Oncol. 19:127–132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang HJ: Aberrant DNA methylation in
cervical carcinogenesis. Chin J Cancer. 32:42–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boyd KE and Farnham PJ: Coexamination of
site-specific transcription factor binding and promoter activity in
living cells. Mol Cell Biol. 19:8393–8399. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li L, Xu C, Long J, Shen D, Zhou W, Zhou
Q, Yang J and Jiang M: E6 and E7 gene silencing results in
decreased methylation of tumor suppressor genes and induces
phenotype transformation of human cervical carcinoma cell lines.
Oncotarget. 6:23930–23943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Au Yeung CL, Tsang WP, Tsang TY, Co NN,
Yau PL and Kwok TT: HPV-16 E6 upregulation of DNMT1 through
repression of tumor suppressor p53. Oncol Rep. 24:1599–1604.
2010.PubMed/NCBI
|
|
22
|
Fatemi M1, Hermann A, Gowher H and Jeltsch
A: Dnmt3a and Dnmt1 functionally cooperate during de novo
methylation of DNA. Eur J Biochem. 269:4981–4984. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feng C, Dong J, Chang W, Cui M and Xu T:
The progress of methylation regulation in gene expression of
cervical cancer. Int J Genomics. 2018:82606522018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Burgers WA, Blanchon L, Pradhan S, de
Launoit Y, Kouzarides T and Fuks F: Viral oncoproteins target the
DNA methyltransferases. Oncogene. 26:1650–1655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van der Graaf Y and Vooijs GP: False
negative rate in cervical cytology. J Clin Pathol. 40:438–442.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sprenger E, Schwarzmann P, Kirkpatrick M,
Fox W, Heinzerling RH, Geyer JW and Knesel EA: The false negative
rate in cervical cytology. Comparison of monolayers to conventional
smears. Acta Cytol. 40:81–89. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jahic M and Jahic E: Diagnostic approach
to patients with atypical squamous cells of undetermined
significance cytologic findings on cervix. Med Arch. 70:296–298.
2016. View Article : Google Scholar : PubMed/NCBI
|
